G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of rat olfactory bulb

British Journal of Pharmacology

Volumn 143, Issue 5, 2004, Pages 638-648

  Onali, Pierluigi ^a   Olianas, Maria C ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

35S GTP S binding; Adenylyl cyclase; Naloxone benzoylhydrazone; Olfactory bulb; Opioid receptors; ORL1 receptor

Indexed keywords

1 (1 CYCLOOCTYLMETHYL 3 HYDROXYMETHYL 4 PIPERIDYL) 3 ETHYL 1,3 DIHYDRO 2H BENZAMIDAZOL 2 ONE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ADENYLATE CYCLASE; BENZAMIDE DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR 3; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHICEPTIN[3 (N METHYLPHENYLALANINE) 4 DEXTRO PROLINAMIDE]; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE BENZOYLHYDRAZONE; NOCICEPTIN; NORBINALTORPHIMINE; OPIATE ANTAGONIST; OPIATE RECEPTOR LIKE RECEPTOR 1 ANTAGONIST; PERTUSSIS TOXIN; PHENYLALANINE DERIVATIVE; PIPERIDINE DERIVATIVE; SULFUR 35; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; GRANULE CELL; MALE; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RAT STRAIN; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); INJECTIONS; MALE; NALOXONE; NEUROTRANSMITTER AGENTS; OLFACTORY BULB; PERTUSSIS TOXIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; TISSUE DISTRIBUTION;

EID: 8744261578     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705951     Document Type: Article

References (47)

1. ABDULLA, F.A. & SMITH, P.A. (1997). Nociceptin inhibits T-type Ca2+ channel current in rat sensory neurons by a G-protein-independent mechanism. J. Neurosci., 17, 8721-8728.
2. BERZETEI-GURSKE, I.P., WHITE, A., POLGAR, W., DeCOSTA, B.R., PASTERNAK, G.W. & TOLL, L. (1995). The in vitro pharmacological characterization of naloxone benzoylhydrazone. Eur. J. Pharmacol., 277, 257-263.
3. BIGONI, R., CAO, G., RIZZI, A., OKAWA, H., REGOLI, D., SMART, D. & LAMBERT, D.G. (2002). Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors. Can. J. Physiol. Pharmacol., 80, 407-412.
4. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
5. 3H-Naloxone benzoylhydrazone binding in MOR-1-transfected Chinese hamster ovary cells: evidence for G-protein-dependent antagonist binding. J. Pharmacol. Exp. Ther., 286, 376-381.
6. 2, a new selective nociceptin receptor antagonist. Br. J. Pharmacol., 129, 1183-1193.
7. CALO', G., GUERRINI, R., RIZZI, A., SALVADORI, S. & REGOLI, D. (2000b). Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol., 129, 1261-1283.
8. CHANG, K.J., WEI, E.T., KILLIAN, A. & CHANG, J.-K. (1983). Potent morphiceptin analogs: structure activity relationships and morphine-like activities. J. Pharmacol. Exp. Ther., 277, 403-408.
9. 3 opiate receptor binding in the mouse and rat. Eur. J. Pharmacol. Mol. Pharmacol. Sect., 226, 15-20.
10. 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line. J. Neurochem., 65, 170-175.
11. CHENG, Y.C. & PRUSOFF, W.H. (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3102.
12. CHIOU, L.-C. (2001). Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying by nociceptin and a μ-opioid in rat periaqueductal grey slices. Naunyn-Schmiedeberg's Arch. Pharmacol., 363, 583-589.
13. 3 subtype. J. Pharmacol. Exp. Ther., 251, 461-468.
14. CRUCIANI, R.A., DVORKIN, B., MORRIS, S.A., CRAIN, S.M. & MAKMAN, M.H. (1993). Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc. Natl. Acad. Sci. U.S.A., 90, 3019-3023.
15. DHAWAN, B.N., CESSELIN, F., RAGHUBIR, R., REISINE, T., BRADLEY, P.B., PORTOGHESE, P.S. & HAMON, M. (1996). International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., 48, 567-592.
16. DUNNILL, R.J., KAKIZAWA, K., MCKNIGHT, A.T. & HENDERSON, G. (1996). Characterization of the actions of naloxone benzoylhydrazone at μ-opioid, κ-opioid and ORL1 receptors in isolated tissues from rat and guinea pig. Br. J. Pharmacol., 119, 275P.
17. ERSPAMER, V., MELCHIORRI, P., FALCONIERI-ERSPAMER, G., NEGRI, L., CORSI, R., SEVERINI, C., BARRA, D., SIMMACO, M. & KREIL, G. (1989). Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for κ opioid binding sites. Proc. Natl. Acad. Sci. U.S.A., 80, 5871-5874.
18. i-protein βγ subunits. Nature, 36, 159-161.
19. FLEMING, W.W., WESTFALL, D.P., DE LA LANDE, S. & JELLET, L.B. (1972). Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther., 181, 339-345.
20. KINSLEY, C.H., MORSE, A.C., ZOUMAS, C., CORL, S. & BILLACK, B. (1995). Intracerebroventricular infusions of morphine, and blockade with naloxone, modify the olfactory preferences for pups odors in lactating rats. Brain Res. Bull., 37, 103-107.
21. MANSOUR, A., FOX, C.A., AKIL, H. & WATSON, S.J. (1995). Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci., 18, 22-29.
22. MATHIS, J.P., MANDYAM, C.D., ALTEMEMI, G.F., PASTERNAK, G.W. & STANDIFER, K.M. (2001). Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells. Neurosci. Lett., 299, 173-176.
23. MEUNIER, J.C., MOLLERAU, C., TOLL, L., SUAUDEAU, C, MOISAND, C., ALVINERIE, P., BUTOUR, J.L., GUILLEMOT, J.C., FERRARA, P., MONSERRAT, B., MAZARGUIL, H., VASSART, G., PARMENTIER, M. & COSTENTIN, J. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 377, 532-535.
24. MOGIL, J.S. & PASTERNAK, G.W. (2001). The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor. Pharmacol. Rev., 53, 381-415.
25. MORI, K., NAGAO, H. & YOSHIHARA, Y. (1999). The olfactory bulb: coding and processing of odor molecule information. Science, 286, 711-715.
26. NABESHIMA, T., NODA, Y. & MAMIYA, T. (1999). The role of nociceptin in cognition. Brain. Res., 848, 167-173.
27. NODA, Y., MAMIYA, T., NABESHIMA, T., NISHI, M., HIGASHIOKA, M. & TAKESHIMA, H. (1998). Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice. J. Biol. Chem., 273, 18047-18051.
28. OLIANAS, M.C. & ONALI, P. (1992). Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb. Mol. Pharmacol., 42, 109-115.
29. 2+/ calmodulin- and forskolin-stimulated enzyme activities in rat olfactory bulb. J. Neurochem., 63, 161-168.
30. OLIANAS, M.C. & ONALI, P. (1999). Mediation by G protein βγ subunits of the opioid stimulation of adenylyl cyclase activity in rat olfactory bulb. Biochem. Pharmacol., 57, 649-652.
31. 3 opioid receptors positively coupled to adenylyl cyclase in rat olfactory bulb. Proc. Soc. Neurosci., 643, 1.
32. ONALI, P., INGIANNI, A. & OLIANAS, M.C. (2001). Dual coupling of opioid receptor-like (ORL1) receptors to adenylyl cyclase in the different layers of the rat main olfactory bulb. J. Neurochem., 77, 1520-1530.
33. OZAKI, S., KAWAMOTO, H., ITOH, Y., MIYAJI, M., IWASAWA, Y & OHTA, H. (2000). A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397. Eur. J. Pharmacol., 387, R17-R18.
34. 3-related opioid receptor. Mol. Pharmacol., 47, 1180-1188.
35. PAUL, D., LEVISON, J.A., HOWARD, D.H., PICK, C.G., HANN, E.F. & PASTERNAK, G.W. (1990). Naloxone benzoylhydrazone (NalBzoH) analgesia. J. Pharmacol. Exp. Ther., 255, 769-774.
36. PELTON, J.T., KAZMIERSKI, W., GULYA, K., YAMAMURA, H.I. & HRUBY, V.J. (1986). Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for μ opioid receptors. J. Med. Chem., 29, 2370-2375.
37. PRATHER, P.L., McGINN, T.M., CLAUDE, P.A., LIU-CHEN, L.Y., LOH, H.H. & LAW, P.Y. (1995). Properties of a κ-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual Gα subunit and is similar to that of other opioid receptors. Mol. Brain Res., 29, 336-346.
38. 3H]naloxone benzoylhydrazone: a reversible κ and slowly dissociable μ opiate. Mol. Pharmacol., 35, 67-74.
39. REINSCHEID, R.K., NOTHACKER, H.P., BOURSON, A., ARDATI, A., HENNINGSEN, R.A., BUNZOW, J.R., GRANDY, D.K., LANGEN, H., MOSMA, F.J. & CIVELLI, O. (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science, 270, 792-794.
40. REMMERS, A.E., CLARK, M.J., MANSOUR, A., AKIL, H., WOODS, J.H. & MEDZIHRADSKY, F. (1999). Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor. J. Pharmacol. Exp. Ther., 288, 827-833.
41. ROTH, T.L. & SULLIVAN, R.M. (2003). Consolidation and expression of a shock-induced odor preference in rat pups is facilitated by opioids. Physiol. Behav., 78, 135-142.
42. SALOMON, Y., LONDOS, D. & RODBELL, M. (1974). A highly sensitive adenylate cyclase assay. Anal. Biochem., 58, 541-548.
43. SCHILLER, P.W., NGUYEN, T.M.-D., WELTROWSKA, G., WILKERS, B.C., MARSDEN, B.J., LEMIEUX, C. & CHUNG, N.N. (1992). Differential stereochemical requirements of μ vs δ 5 opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists. Proc. Natl. Acad. Sci. U.S.A., 89, 11871-11875.
44. 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. J. Pharmacol. Exp. Ther., 270, 1246-1255.
45. SUNAHARA, R.K., DESSAUER, C.W. & GILMAN, A.G. (1996). Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol., 36, 461-480.
46. TAKEMORI, A.E., HO, B.Y., NAESETH, J.S. & PORTOGHESE, P.S. (1988). Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther., 246, 255-258.
47. WANG, L. & GINTZLER, A.R. (1997). Altered μ-opiate receptor-G protein signal transduction following chronic morphine exposure. J. Neurochem., 68, 248-254.